standard]
MCIVYIVYLGALPQGDYAPVSHHAKILQEVVSDSFPTKSLVRSYTRSFNA
FAANLTDQEQKKLASHDDVVSVFPSTTLQRQTTRSWDFMGFHQNVRRNPA
VESDIIIGVIDDGIWPESESFSDRGFGPVPKKWKGACNGGEDFTCNNKII
GARWYTALDASVKDGSGHGTICASIAAGNYVNNASFYGIAQGTARGGVPA
ARIAAYKACGGIGCESVDLLSAFNDAIADGVDIISLSLGGGILDIKDDVV
AIGALHAMQKGILTVNAGGNSGHGSGRKSITASVAPWLFSVAASTTDRRI
VTKVALGNGATIIGKGVNSFKQNSKKFTLIHGKNATASKCTEKAAKLCED
GCLNSRLVKGNILICEDANRQRQAMDAGAYGVIEMADDEFSSVTALPASD
LSLQNIRQIQDYAKNTIMAVANILTSESTKQSDAPIVARFSSRGPNLLIP
EIMKPDVTAPGVEILAAYSPKESPSNYHFDDRSVKYTIVSGTSMACPHVA
GAAAYVKSMHPNWSPSVIKSALMTTARPMASAKGKHTEFSYGAGHINPVK
AANPGLVYETIEEEYVKLLCYKGYSTPTIRKLFGNKRSNCSRLKHRNWSP
KDLNYPAMASLVRRNESFTVIFSRTVTNVGDASSTYRANISAPPGLKVIV
QPPELPLKKLNEKKSFVVKVGGKVAVRVLSASLEWNDGNHNVRSPIVIYT
KSPKIS
|
IPR000209; Peptidase S8/S53, subtilisin/kexin/sedolisin IPR010259; Proteinase inhibitor I9, subtilisin propeptide IPR022398; Peptidase S8/S53, subtilisin, active site |